SpicyIP

AUGUST 15, 2021

Topical Highlight. Ensuring Access to TB drugs: Is Compulsory License the Way? They highlight that this failure is typified by the stark realities that have come to light in a pending public interest litigation before the Bombay High Court [BHC], regarding access to life saving drugs. Thematic Highlight.

Licensing 83

Licensing Government Reporting Patent Law 83

The IPKat

AUGUST 31, 2022

The IPKat is pleased to host the following contribution by Katfriend Marianna Ryan (Edwin Coe and King's College London) on the topical issue of how Decentralised Autonomous Organisations (DAOs) are to be treated and what IP issues come with them. Here's what Marianna writes: Ownership of IP rights by DAOs – the future is nigh?

Ownership 134

Ownership IP Contracts Inventor 134

LexBlog IP

MARCH 8, 2023

We also have an upcoming webinar covering the topic in March – details here.) Further, the test was designed to evaluate whitening toothpaste and only looked at extrinsic stain removal; it did not include an assessment of intrinsic (or below the surface) stain removal. We shall see. But there is more. Why does this matter?

Advertising 52

Advertising Advertising Branding Brands 52

Technology & Marketing Law Blog

JANUARY 9, 2024

Snap workaround of claiming to sue over Snap’s first-party product design choices, not the drug dealers’ content: Plaintiffs disavow any claim based upon Snap’s activities as a publisher of the third-party (drug seller) content. ” The plaintiffs are claiming this, but is it correct?

Publishing 75

Publishing Designs Design Law 75

43(B)log

MARCH 25, 2024

Food & Drug Admin., NIFLA says that abortion is a controversial topic, making disclosures about abortion controversial; but NetChoice said that “ disclosures of social media censorship decisions” were not controversial. R J Reynolds Tobacco Co. 2024 WL 1208111, F.4th 23-40076 (5 th Cir. Images can be factual. “

Advertising 64

Advertising Advertising Social Media Government 64

Velocity of Content

FEBRUARY 22, 2023

As mentioned above, RightFind Navigate added ChemBL Compounds as a data source, which brings in a new layer of access to bioactive compounds with drug-like properties. The relevance of a search depends highly on having access to the data sources used by your organization. Navigate also leverages ChemBL as a vocabulary.

Branding 98

Branding Brands Branding Licensing 98

LexBlog IP

OCTOBER 19, 2023

” Individualized CGTs are therapies “developed for a single patient (or a very small number of patients) based on designing or engineering a product that specifically targets the mechanism underlying a patient’s (or small number of patients’) illness.” ” FDA’s request focuses on three core areas: 1.

Editing 52

Editing Designs Design Technology 52

SpicyIP

JANUARY 2, 2022

This year, we have divided these developments into three categories: a) Top 10 IP Judgments/Orders (Topicality/Impact). Top 10 Judgments/Orders [Topicality/Impact]. Hetero Drugs Ltd [Delhi High Court]. Hetero Drugs claimed that the drug was not being used in India and the export was only for research and development purposes.

IP 143

IP Intellectual Property Copyright Trademark 143

SpicyIP

FEBRUARY 12, 2024

Last week we published 9 posts on topics such as our comments on the proposed Trademarks (1st Amendment) Rules, the Madras High Court’s decision with respect to patentability of business methods, and Union Minister of State for Commerce’s response on ability of the current IPR regime to cater concerns arising out of AI generated work.

Trademark 103

Trademark Social Media Registering Trademarks Copyright 103

Velocity of Content

JANUARY 26, 2022

In RightFind, reseachers and investigators can analyze previously published studies and create reviews of articles pertaining to a topic, such as a specific disease, chemical compound, or ingredient. Even when coming up with a brand-new product, almost all R&D projects involve some level of assessment of the current research landscape.

Marketing 98

Marketing Marketing Licensing Publishing 98

SpicyIP

DECEMBER 30, 2023

As in previous years, we have divided these developments into five categories: a) Top 10 IP Judgements/Orders (Topicality/Impact) b) Top 10 IP Judgements/Orders (Jurisprudence/Legal Lucidity) c) Top 10 IP Legislative and Policy Related Developments d) Other IP Developments; and e) Other Notable Developments. RDB and Co. Hari Shankar.

IP 124

IP Copyright Trademark Intellectual Property 124

SpicyIP

FEBRUARY 5, 2024

Last week we published 9 posts on topics such as the Patent (2 nd Amendment) Rules, the Delhi High Court-Butter Chicken Controversy, and developments regarding the public search and e-register feature of the TMR website. Unfortunately, the issue of similar brand names for different drugs treating different ailments is pretty common in India.

Trademark 59

Trademark Settlement Licensing Copyright Infringement 59

SpicyIP

JULY 19, 2021

Topical Highlight. She argues that unlike the Attars of Kannauj which are designated as Geopgraphical Indication, all small traditional businesses of Attars and Agarbattis do not enjoy such privilege, and thus, protection as smell marks may lend necessary protection to such TCE. News from India. Other News from Around the World.

Advertising 105

Advertising Advertising Non-Fungible Tokens Intellectual Property 105

SpicyIP

DECEMBER 24, 2023

In this month’s edition, he looks into topics including the Plant Variety Registry, different tales of/ takes on personality rights, and multiple leaks of key documents and their contribution in law-making. crores, which was 3/4th of the total claimed amount, as a pro-tem deposit. Pharmacyclics LLC & Anr.

Registration 52

Registration Trademark Copyright Registering Trademarks 52

Fish & Richardson Trademark & Copyright Thoughts

JANUARY 11, 2022

2021 saw several important milestones in the biosimilars space, including the much anticipated first interchangeable designations by FDA and the approval of the first ophthalmology biosimilar. Biosimilar Drug. Tackling Biologic Drug Pricing. Introduction. Biosimilars Approved as of 2021. Reference Product. Biosimilar Code Name.

Litigation 52

Litigation Settlement Patent Marketing 52

Fish & Richardson Trademark & Copyright Thoughts

FEBRUARY 7, 2022

Following a year in which only three post-grant petitions were filed against patents covering biologic drugs, 2021 saw 18 biologic IPR petitions and 5 biologic PGR petitions filed. With this new decision from the POP, 2022 already has one more decision designated precedential than 2021. Back to Top. Back to Top.

Reporting 52

Reporting Art Invention Patent 52

LexBlog IP

DECEMBER 31, 2022

In the intellectual property (IP) space, there has been explosive growth in this area, with AI-based patent filings addressing trending areas, including disease identification and diagnosis, drug discovery, personalized medicine, and clinical trials, among others. Drug Discovery and Manufacture. Clinical Trials.

Intellectual Property 52

Intellectual Property IP Technology Privacy 52

Technology & Marketing Law Blog

JANUARY 7, 2023

This can be particularly challenging when this uncertainty is prolonged, and the topic has no clear authority. However, with topics such as 5G telecommunications, it has been more difficult for platforms to quickly identify trustworthy sources of evidence and advice. * DEA , Emoji Drug Code Decoded. Emojis and Memes.

Social Media 75

Social Media Marketing Marketing Technology 75